ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4806
0.05%
Brent Oil
82.095
-0.04%
Bitcoin
66,455.76
-0.27%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Calmare Therapeutics Inc (CE) (CTTC)

  7. Calmare Therapeutics Inc (CE) (CTTC) Noticias

CTTC

Calmare Therapeutics (CE) (CTTC)

Calmare Therapeutics Inc (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:CTTC
FechaHoraFuenteTítuloSímboloCompañía
09/06/202016:27Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
11/02/202014:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CTTCCalmare Therapeutics Inc (CE)
02/07/201817:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
02/07/201817:14Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:CTTCCalmare Therapeutics Inc (CE)
06/03/201812:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CTTCCalmare Therapeutics Inc (CE)
20/02/201808:47Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
13/02/201812:43Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CTTCCalmare Therapeutics Inc (CE)
16/01/201816:16Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
12/01/201805:06Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
02/01/201805:05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
05/12/201710:00Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
04/12/201714:06Edgar (US Regulatory)Proxy Statement - Contested Solicitations (preliminary) (prec14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
22/11/201715:44Edgar (US Regulatory)Proxy Statements Not Involving Contested Solicitations (preliminary) (pren14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
15/11/201716:16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CTTCCalmare Therapeutics Inc (CE)
21/09/201709:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CTTCCalmare Therapeutics Inc (CE)
21/07/201716:00Edgar (US Regulatory)Annual Report (10-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
30/06/201716:06Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:CTTCCalmare Therapeutics Inc (CE)
31/03/201715:42Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
29/12/201615:09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTTCCalmare Therapeutics Inc (CE)
25/10/201616:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
09/12/201405:01Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)USOTC:CTTCCalmare Therapeutics Inc (CE)
14/11/201405:02Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:CTTCCalmare Therapeutics Inc (CE)
03/07/201414:18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTTCCalmare Therapeutics Inc (CE)
30/04/201416:30Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CTTCCalmare Therapeutics Inc (CE)
01/04/201415:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)USOTC:CTTCCalmare Therapeutics Inc (CE)
01/04/201415:13Edgar (US Regulatory)(40-17F1)USOTC:CTTCCalmare Therapeutics Inc (CE)
06/12/201314:00ZacksSouFun Prices Senior Notes - Analyst BlogUSOTC:CTTCCalmare Therapeutics Inc (CE)
05/11/201312:19MarketwiredCalmare Pain Relief Solutions Adds New Calmare(R) Pain Therapy ClinicsUSOTC:CTTCCalmare Therapeutics Inc (CE)
15/10/201311:54OTC MarketsCompetitive Tech Selected To Provide Pain Care Training To U.S. Military PersonnelUSOTC:CTTCCalmare Therapeutics Inc (CE)
04/10/201308:00OTC MarketsCompetitive Tech Appoints Conrad F. Mir as New President, CEO & Member of the BoardUSOTC:CTTCCalmare Therapeutics Inc (CE)
 Showing the most relevant articles for your search:USOTC:CTTC

Su Consulta Reciente

FX
USDMXN
US Dollar vs MXN
NASDAQ
TSLA
Tesla
AMEX
SPY
SPDR S&P 500
USOTC
BNPQY
BNP Paribas (QX)
USOTC
BASFY
BASF (QX)
NYSE
KO
Coca Cola
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
CCOM
OILBRENT
Brent Oil
PM
XAUUSD
Gold vs US Dollar
NYSE
CVX
Chevron
NYSE
DIS
Walt Disney
AMEX
XLV
Health Care Select Sector
CCOM
SILVER
SILVER
NYSE
NKE
Nike
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados